Aldeyra Therapeutics Inc (NASDAQ:ALDX)

8.51
Delayed Data
As of Sep 24
 +0.11 / +1.31%
Today’s Change
6.21
Today|||52-Week Range
15.95
+24.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-12.1M-18.7M-22.3M-38.9M
 
 
 
 
 
Depreciation18.8K35.8K37.8K71.0K
 
 
 
 
 
Total Other Cash Flow2.2M3.1M2.7M4.0M
 
 
 
 
 
Funds From Operations-9.9M-15.6M-19.6M-34.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-536.8K-463.0K-215.5K-5.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-9.3M-15.1M-19.4M-29.9M
 
 
 
 
 
 
InvestingIncrease In Investments-13.0M-16.0M-35.1M-59.7M
 
 
 
 
 
Decrease In Investments0.0015.8M24.9M36.7M
 
 
 
 
Capital Expenditures-86.1K-11.8K-24.8K-263.0K
 
 
 
 
 
Net Cash Flow Investing-13.0M-225.2K-10.2M-23.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale28.5M12.7M37.5M81.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00125.3K0.00
 
 
Other Uses - Financing0.000.000.001.4M
 
 
Net Cash Flow - Financing28.5M12.7M37.6M80.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash6.1M-2.6M8.0M27.3M